Post by
Duster340 on Mar 26, 2024 9:27am
It does not make a lot of sense
that nuance would burn through there own cash to let antibe carry on with the P2 trials. what if the drug is unsuccessful? the burden of bringing the drug to a point where there would be potential partners or to a point were they could have got a financing deal was squandered by a poorly run company. nuance has got antibe over the barrel, if for some reason they were to throw out a life line it will not favor antibe or it's share holders.
glta
Comment by
Inthepez on Mar 26, 2024 9:12pm
Then why are you wasting your time constantly posting about a company that has "better than 50% chance of going under"? Peasant penny flipper lol!